These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18376816

  • 1. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T, Pevsner-Fischer M, Cohen N, Cohen IR, Shai Y.
    Biochemistry; 2008 Apr 22; 47(16):4826-33. PubMed ID: 18376816
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M, Rucker J, Hoffman TL, Doms RW, Shai Y.
    Biochemistry; 1999 Aug 31; 38(35):11359-71. PubMed ID: 10471286
    [Abstract] [Full Text] [Related]

  • 5. A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.
    Faingold O, Cohen T, Shai Y.
    J Biol Chem; 2012 Sep 28; 287(40):33503-11. PubMed ID: 22872636
    [Abstract] [Full Text] [Related]

  • 6. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study.
    Sackett K, Shai Y.
    J Mol Biol; 2005 Jul 22; 350(4):790-805. PubMed ID: 15964015
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.
    Quintana FJ, Gerber D, Kent SC, Cohen IR, Shai Y.
    J Clin Invest; 2005 Aug 22; 115(8):2149-58. PubMed ID: 16007266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex.
    Lorizate M, Gómara MJ, de la Torre BG, Andreu D, Nieva JL.
    J Mol Biol; 2006 Jun 30; 360(1):45-55. PubMed ID: 16813835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J, Norley S, Kurth R.
    AIDS; 1994 Aug 30; 8(8):1063-72. PubMed ID: 7986401
    [Abstract] [Full Text] [Related]

  • 16. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M, Lemay G, Cohen EA.
    Virus Res; 2007 Mar 30; 124(1-2):103-12. PubMed ID: 17129629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS, Lee SF, Wang CT.
    J Virol; 2001 Oct 30; 75(20):9925-38. PubMed ID: 11559825
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
    Lev N, Fridmann-Sirkis Y, Blank L, Bitler A, Epand RF, Epand RM, Shai Y.
    Biochemistry; 2009 Apr 14; 48(14):3166-75. PubMed ID: 19206186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.